MarketCap
Facebook
X
TelegramAnnual report 2023
added 02-29-2024
PetIQ Depreciation & Amortization 2011-2025 | PETQ
Annual Depreciation & Amortization PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.5 M | 35.5 M | 39.3 M | 27.5 M | 16.5 M | 12.5 M | 3.61 M | 4.07 M | 3.14 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.5 M | 3.14 M | 20.7 M |
Quarterly Depreciation & Amortization PetIQ
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 M | - | 3.58 M | 17.7 M | 8.97 M | - | 28.9 M | 20.4 M | 12.4 M | - | 18.9 M | 11.2 M | 5.47 M | - | 11 M | 6.06 M | 3.09 M | - | 8.93 M | 5.71 M | 2.52 M | - | 2.72 M | 1.69 M | 851 K | - | 2.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.9 M | 851 K | 9.19 M |
Depreciation & Amortization of other stocks in the Drug manufacturers industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Canopy Growth Corporation
CGC
|
21.5 M | $ 1.74 | - | $ 187 M |  Canada |
 |
Alimera Sciences
ALIM
|
8.75 M | - | - | $ 142 M |  USA |
 |
Assertio Holdings
ASRT
|
28.2 M | $ 0.76 | - | $ 54 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
6.4 M | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
311 K | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.48 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
102 K | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
489 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
31 K | - | - | $ 50.1 M | USA |
 |
Organogenesis Holdings
ORGO
|
13.6 M | $ 4.82 | - | $ 635 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
646 K | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
306 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
125 M | $ 11.41 | - | $ 584 M | USA |
 |
Pacira BioSciences
PCRX
|
78.8 M | $ 26.29 | - | $ 1.22 B | USA |
 |
Athenex
ATNX
|
4.47 M | - | -23.39 % | $ 1.76 M | USA |
 |
Rockwell Medical
RMTI
|
1.44 M | $ 0.92 | - | $ 21.5 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
2.68 M | $ 21.36 | - | $ 2.03 B |  France |
 |
Solid Biosciences
SLDB
|
2.46 M | $ 5.87 | - | $ 240 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
138 K | $ 3.59 | - | $ 4.46 M | USA |
 |
Evolus
EOLS
|
5.3 M | $ 7.04 | 1.88 % | $ 437 M | USA |
 |
Harrow Health
HROW
|
1.06 M | $ 47.06 | - | $ 1.53 B | USA |
 |
China Pharma Holdings
CPHI
|
2.62 M | $ 1.55 | -0.38 % | $ 27.1 M |  China |
 |
Veru
VERU
|
268 K | $ 2.42 | - | $ 326 M | USA |
 |
Bausch Health Companies
BHC
|
1.26 B | $ 6.92 | - | $ 2.53 B | Canada |
 |
Lannett Company
LCI
|
34.3 M | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4.9 M | $ 2.53 | 1.61 % | $ 35.6 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.26 M | - | - | $ 193 M | Canada |
 |
Relmada Therapeutics
RLMD
|
1.26 K | $ 4.06 | - | $ 122 M | USA |
 |
Jupiter Wellness
JUPW
|
429 K | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
326 M | $ 13.14 | - | $ 1.81 B | USA |
 |
ProPhase Labs
PRPH
|
4.72 M | $ 0.11 | - | $ 1.74 M | USA |
 |
Radius Health
RDUS
|
1.16 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
8.22 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
402 K | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
116 K | - | -27.8 % | $ 2.56 M | USA |
 |
cbdMD
YCBD
|
452 K | $ 1.2 | - | $ 5.18 M | USA |
 |
SCYNEXIS
SCYX
|
580 K | $ 0.65 | - | $ 31.1 M | USA |
 |
Tricida
TCDA
|
442 K | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
35.7 M | $ 12.15 | - | $ 7.51 B | Canada |
 |
TherapeuticsMD
TXMD
|
922 K | $ 1.75 | - | $ 18.3 M | USA |
 |
Zomedica Corp.
ZOM
|
830 K | - | -0.21 % | $ 98 M | USA |
 |
Viatris
VTRS
|
3.03 B | $ 11.65 | - | $ 14.1 B | USA |